Quality Electrodynamics (QED) was one of the local recipients of
Ohio Third Frontier funding for the development of an imaging system that will improve the way doctors evaluate whether a kidney is viable for donation.
The Cleveland-based company, working with the Cleveland Clinic’s
Glickman Urological Institute,
CWRU, Toshiba Medical Systems and Canon, received $1 million for the development of specialty MRI coils for imaging donor kidneys before transplant to determine viability.
Currently, potentially viable kidneys are sometimes rejected for transplant, or there are complications after transplant. This technology will improve the chances of success as well as reduce the number of kidneys that are thrown away.
“The program will result in a turnkey system of equipment, analysis software and clinical protocols which will be marketed to transplant centers on a worldwide basis,” says John L. Patrick, chief technical marketing officer for QED.
“Recipients of kidneys from deceased donors would benefit in several ways: Higher confidence level that the transplanted kidney can be viable and better knowledge of its condition; increase of transplanted kidneys by reducing the number of viable kidneys discarded will increase the number of patients able to benefit from transplantation.”
Patrick says the technology should be on the market in less than two years, depending on how clinical trials go. QED expects to begin hiring additional people for development of the technology in the next few months.
“In the proposal we stated that 38 jobs would be created at QED within 3 years,” says Patrick. “In fact, we believe that number to be quite conservative.”
Source: John L. Patrick
Writer: Karin Connelly
This story originally appeared in sister publication Fresh Water Cleveland.